Wednesday, July 8, 2026

Patent intelligence · US

US 9067962

Methods of treating diabetes

granted A61KA61K31/7028A61K31/7034A61P
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 9
Applicant portfolio 102
Patent details — US 9067962
Jurisdiction
US
Status
granted
Grant date
Jun 30, 2015
Expiration
Jun 25, 2035
Claims
16
CPC classes
A61K, A61K31/7028, A61K31/7034, A61P
View on Google Patents ↗

Quick answer

US 9067962 (Methods of treating diabetes) is held by LEXICON PHARMACEUTICALS, INC.. Status: granted. Granted Jun 30, 2015. Expires Jun 25, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
16
CPC classes
A61K, A61K31/7028, A61K31/7034, A61P, A61P3/00, A61P3/04

More from LEXICON PHARMACEUTICALS, INC.

Related pharmaceutical patents in our USPTO index.

  1. US 12344596

    Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof

    LEXICON PHARMACEUTICALS, INC. · Expires Jun 26, 2045

    granted
  2. US 11730723

    Compounds and methods for treating viral infections

    LEXICON PHARMACEUTICALS, INC. · Expires Aug 17, 2043

    granted
  3. US 11666575

    Pyrazolo[1,5]pyrimidine-based compounds and methods of their use to treat viral infections

    LEXICON PHARMACEUTICALS, INC. · Expires Jun 1, 2043

    granted
  4. US 11059907

    Antibodies that bind Notum Pectinacetylesterase

    LEXICON PHARMACEUTICALS, INC. · Expires Jul 8, 2041

    granted
  5. US 10106569

    Inhibitors of sodium glucose transporter 1 for constipation

    LEXICON PHARMACEUTICALS, INC. · Expires Oct 18, 2038

    granted
  6. US 9862724

    Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Expires Jan 4, 2038

    granted
  7. US 9688710

    Inhibitors of sodium glucose cotransporter 1

    LEXICON PHARMACEUTICALS, INC. · Expires Jun 22, 2037

    granted
  8. US 9682982

    Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Expires Jun 15, 2037

    granted

Frequently asked questions

What is US patent 9067962?

US 9067962 (Methods of treating diabetes) is held by LEXICON PHARMACEUTICALS, INC.. Status: granted. Granted Jun 30, 2015. Expires Jun 25, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 9067962?

LEXICON PHARMACEUTICALS, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 102 pharmaceutical patents for this assignee.

When does US 9067962 expire?

Our index shows an expiration date of Jun 25, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.